Company: GANX
Filing Date: 2025-12-03
Form Type: S-8
Source: 0001104659-25-118118
Chunk: 4

Company: Gain Therapeutics, Inc.
Filing Date: 2025-12-03
Form: S-8
Chunk 4
---
 to this registration statement, to any and all amendments
or supplements to this registration statement and to any and all instruments or documents filed as part of or in connection with this
registration statement or any and all amendments thereto; and each of the undersigned hereby ratifies and confirms all that such attorneys
and agents, or either of them, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities
Act of 1933, as amended, this Registration Statement on Form S-8 has been signed by the following persons in the capacities and
on the dates indicated.

| Signature             
 /s/ Gene Mack         |     | Title                                    
 Chief Executive Officer                  
 and Director                             |     | Date             
 December 3, 2025 |
|:----------------------|:----|:-----------------------------------------|:----|:-----------------|
| Gene Mack             |     | -Principal Executive                     
 Officer                                  |     |                  |
| /s/ Gianluca Fuggetta |     | Senior                                   
 Vice President Finance                   |     | December 3, 2025 |
| Gianluca Fuggetta     |     | -Principal Financial                     
 Officer and Principal Accounting Officer |     |                  |
| /s/ Khalid Islam      
 Khalid Islam          |     | Chairman                                 
 of the Board of Directors                |     | December 3, 2025 |
| /s/ Dov Goldstein     
 Dov Goldstein         |     | Director                                 |     | December 3, 2025 |
| /s/ Hans Peter Hasler 
 Hans Peter Hasler     |     | Director                                 |     | December 3, 2025 |
| /s/ Gwen Melincoff    
 Gwen Melincoff        |     | Director                                 |     | December 3, 2025 |
| /s/ Claude Nicaise    
 Claude Nicaise        |     | Director                                 |     | December 3, 2025 |
| /s/ Jeffrey           
 Riley                 |     | Director                                 |     | December 3, 2025 |
| Jeffrey Riley         |     |                                          |     |                  |